C12Y 204/02009
Uracil phosphoribosyltransferase
Official title: Uracil phosphoribosyltransferase (2.4.2.9)
C12Y204/02009 (Uracil phosphoribosyltransferase) appears on 5 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 10
- Assignees
- 8
- Inventors
- 32
- Latest grant
- 17 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 1 | 0 |
| 2024 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Suicide gene therapeutic agent for brain tumors using pluripotent stem cell17 Sep 2024US 12,090,172 B2Keio University
- Oncolytic virus for expression of immune checkpoint modulators10 Oct 2023US 11,779,619 B2Transgene S. A.
- Oncolytic virus for expression of immune checkpoint modulators11 Feb 2020US 10,555,981 B2Transgene S.A.
- Poxviral oncolytic vectors27 Jun 2017US 9,687,515 B2Transgene S. A.
- Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases5 Jan 1999US 5,856,153 ACayla
- Therapeutic agent using genome-edited pluripotent stem cell11 Jul 2024US 2024/0226175 A1Keio University
- Genetically modified nk cell line transduced with gene encoding novel chimeric antigen receptor and use thereof20 Oct 2022US 2022/0333079 A1
- Non-viral modification of mesenchymal stem cells25 Aug 2022US 2022/0265723 A1National University of Singapore
- Suicide gene therapeutic agent for brain tumors using pluripotent stem cell2 Dec 2021US 2021/0369785 A1Keio University
- Oncolytic virus for expression of immune checkpoint modulators25 Jun 2020US 2020/0197457 A1Transgene S. A.
Most cited
By later US patents
- Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases11US 5,856,153 ACayla · 1999
- Oncolytic virus for expression of immune checkpoint modulators9US 10,555,981 B2Transgene S.A. · 2020
- Poxviral oncolytic vectors2US 9,687,515 B2Transgene S. A. · 2017